Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers

Fig. 2

Association of genomic features quantifying tumor HRD and immunological characterization in ER + /HER2- tumors (n = 606). Violin plots representing the distribution of HRD, TAI, LST and LOH scores (A), signature 3 proportion (B), and immune signatures (C) according to HRD level and BRCA 1/2 mutational status in ER + /HER2- tumors. *Wilcoxon p-value < 0.05

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us